Genetic counselors' views and experiences with the clinical integration of genome sequencing

Journal of Genetic Counseling

Volumn 23, Issue 4, 2014, Pages 496-505

  Machini, Kalotina ^a   Douglas, Jessica ^b   Braxton, Alicia ^c   Tsipis, Judith ^a   Kramer, Kate ^a  

^a BRANDEIS UNIVERSITY   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Clinical; Genetic counseling; Research; Whole exome sequencing; Whole genome sequencing

Indexed keywords

GENETIC COUNSELING; HEALTH PERSONNEL ATTITUDE; HUMAN; HUMAN GENOME; PSYCHOLOGY;

ATTITUDE OF HEALTH PERSONNEL; GENETIC COUNSELING; GENOME, HUMAN; HUMANS;

EID: 84904255226     PISSN: 10597700     EISSN: 15733599     Source Type: Journal    
DOI: 10.1007/s10897-014-9709-4     Document Type: Article

References (31)

1. American College of Medical Genetics and Genomics. (2012). Points to consider in the clinical application of genomic sequencing. Genetics in Medicine, 14, 759-761.
2. Ashley, E. A.; Butte, A. J.; Wheeler, M. T.; Chen, R.; Klein, T. E.; Dewey, F. E.; et al. (2010). Clinical assessment incorporating a personal genome. Lancet, 375(9725), 1525-1535.
3. Bras, J.; Guerreiro, R.; Hardy, J. (2012). Use of next-generation sequencing and other whole-genome strategies to dissect neurological disease. Nature Reviews Neuroscience, 13(7), 453-464.
4. Brunham, L. R.; Hayden, M. R. (2012). Medicine. Whole-genome sequencing: the new standard of care? Science, 336(6085), 1112-1113.
5. Burniat, A.; Pirson, I.; Vilain, C.; Kulik, W.; Afink, G.; Moreno-Reyes, R.; et al. (2012). Iodotyrosine deiodinase defect identified via genome-wide approach. The Journal of Clinical Endocrinology and Metabolism, 97(7), 1276-1283.
6. Casals, F.; Bertranpetit, J. (2012). Genetics. Human genetic variation, shared and private. Science, 337(6090), 39-40.
7. Dixon-Salazar, T. J.; Silhavy, J. L.; Udpa, N.; Schroth, J.; Bielas, S.; Schaffer, A. E.; et al. (2012). Exome sequencing can improve diagnosis and alter patient management. Science Translational Medicine, 4(138), 138ra178.
8. Gonzaga-Jauregui, C.; Lupski, J. R.; Gibbs, R. A. (2012). Human genome sequencing in health and disease. Annual Review of Medicine, 63, 35-61.
9. Green, R. C.; Berg, J. S.; Grody, W. W.; Kalia, S. S.; Korf, B. R.; Martin, C. L.; et al. (2013). ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genetics in Medicine, 15(7), 565-574.
10. Gymrek, M.; McGuire, A. L.; Golan, D.; Halperin, E.; Erlich, Y. (2013). Identifying personal genomes by surname inference. Science, 339(6117), 321-324.
11. Hastings, R.; de Wert, G.; Fowler, B.; Krawczak, M.; Vermeulen, E.; Bakker, E.; et al. (2012). The changing landscape of genetic testing and its impact on clinical and laboratory services and research in Europe. European Journal of Human Genetics, 20, 911-916.
12. Krier, J. B.; Green, R. C. (2013). Management of incidental findings in clinical genomic sequencing. Current protocols in human genetics/editorial board, Jonathan L. Haines... [et al.], Chapter 9, Unit9 23.
13. Lam, H. Y.; Clark, M. J.; Chen, R.; Natsoulis, G.; O'Huallachain, M.; Dewey, F. E.; et al. (2012). Performance comparison of whole-genome sequencing platforms. Nature Biotechnology, 30(1), 78-82.
14. Lander, E. S.; Linton, L. M.; Birren, B.; Nusbaum, C.; Zody, M. C.; Baldwin, J.; et al. (2001). Initial sequencing and analysis of the human genome. Nature, 409(6822), 860-921.
15. Lerner-Ellis, J. P. (2012). The clinical implementation of whole genome sequencing: a conversation with seven scientific experts. Journal of Inherited Metabolic Disease, 35(4), 689-693.
16. McGuire, A. L.; Joffe, S.; Koenig, B. A.; Biesecker, B. B.; McCullough, L. B.; Blumenthal-Barby, J. S.; et al. (2013). Point-counterpoint. Ethics and genomic incidental findings. Science, 340(6136), 1047-1048.
17. Metzker, M. L. (2005). Emerging technologies in DNA sequencing. Genome Research, 15(12), 1767-1776.
18. Metzker, M. L. (2010). Sequencing technologies - the next generation. Nature Reviews Genetics, 11(1), 31-46.
19. Need, A. C.; Shashi, V.; Hitomi, Y.; Schoch, K.; Shianna, K. V.; McDonald, M. T.; et al. (2012). Clinical application of exome sequencing in undiagnosed genetic conditions. Journal of Medical Genetics, 49(6), 353-361.
20. Ng, S. B.; Buckingham, K. J.; Lee, C.; Bigham, A. W.; Tabor, H. K.; Dent, K. M.; et al. (2010). Exome sequencing identifies the cause of a mendelian disorder. Nature Genetics, 42(1), 30-35.
21. O'Daniel, J. M.; Lee, K. (2012). Whole-genome and whole-exome sequencing in hereditary cancer: impact on genetic testing and counseling. Cancer Journal, 18(4), 287-292.
22. Ormond, K. E.; Wheeler, M. T.; Hudgins, L.; Klein, T. E.; Butte, A. J.; Altman, R. B.; et al. (2010). Challenges in the clinical application of whole-genome sequencing. Lancet, 375(9727), 1749-1751.
23. Rabbani, B.; Mahdieh, N.; Hosomichi, K.; Nakaoka, H.; Inoue, I. (2012). Next-generation sequencing: impact of exome sequencing in characterizing Mendelian disorders. Journal of Human Genetics, 57, 621-632.
24. Robinson, P. N.; Krawitz, P.; Mundlos, S. (2011). Strategies for exome and genome sequence data analysis in disease-gene discovery projects. Clinical Genetics, 80(2), 127-132.
25. Ropers, H. H. (2012). On the future of genetic risk assessment. Journal of Community Genetics, 3(3), 229-236.
26. Stavrou, E. F.; Goriely, A. (2012). Santorini mutation detection meeting 2011: rapid advance in sequencing technology poses challenges for interpretation of genetic variations. Human Mutation, 33(10), 1497-1500.
27. Stenson, P. D.; Ball, E. V.; Howells, K.; Phillips, A. D.; Mort, M.; Cooper, D. N. (2009). The Human Gene Mutation Database: providing a comprehensive central mutation database for molecular diagnostics and personalized genomics. Human Genomics, 4(2), 69-72.
28. Tabor, H. K.; Berkman, B. E.; Hull, S. C.; Bamshad, M. J. (2011). Genomics really gets personal: how exome and whole genome sequencing challenge the ethical framework of human genetics research. American Journal of Medical Genetics Part A, 155A(12), 2916-2924.
29. Tabor, H. K.; Stock, J.; Brazg, T.; McMillin, M. J.; Dent, K. M.; Yu, J. H.; et al. (2012). Informed consent for whole genome sequencing: a qualitative analysis of participant expectations and perceptions of risks, benefits, and harms. American Journal of Medical Genetics Part A, 158A(6), 1310-1319.
30. Townsend, A.; Adam, S.; Birch, P. H.; Lohn, Z.; Rousseau, F.; Friedman, J. M. (2012). "I want to know what's in Pandora's Box": comparing stakeholder perspectives on incidental findings in clinical whole genomic sequencing. American Journal of Medical Genetics Part A, 158A(10), 2519-2525.
31. Worthey, E. A.; Mayer, A. N.; Syverson, G. D.; Helbling, D.; Bonacci, B. B.; Decker, B.; et al. (2011). Making a definitive diagnosis: successful clinical application of whole exome sequencing in a child with intractable inflammatory bowel disease. Genetics in Medicine: Official Journal of the American College of Medical Genetics, 13(3), 255-262.